Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Journal of Clinical and Experimental Hematopathology : JCEH|December 3, 2010
11q23/MLL acute leukemia : update of clinical aspectsHayato Tamai, Koiti Inokuchi
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 17, 2015
[Molecular genetics of acute lymphoblastic leukemia]Hayato Tamai, Koichi Inokuchi
IEEE ... International Conference on Rehabilitation Robotics : [Proceedings]|July 11, 2025
Effects of Deep Core Activation Method Using Wearable Cyborg HAL in a Supine Position for Ameliorating Defecatory Function: A Pilot StudyHayato Tamai, Akira Uehara, Yoshiyuki Sankai, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 10, 2017
Adult T-cell leukemia-lymphoma complicated by Takotsubo cardiomyopathy and HTLV-1-associated myelopathy after treatment with the anti-CCR4 antibody mogamulizumabSatoshi Yamanaka, Kazutaka Nakayama, Hayato Tamai, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 10, 2010
[Epstein-Barr virus-related B-cell lymphoma of the skin which developed early after cord blood transplantation for angioimmunoblastic T-cell lymphoma]Kenji Tajika, Hayato Tamai, Taro Mizuki, et al.
International Journal of Hematology|August 25, 2011
RCSD1-ABL1-positive B lymphoblastic leukemia is sensitive to dexamethasone and tyrosine kinase inhibitors and rapidly evolves clonally by chromosomal translocationsKoiti Inokuchi, Satoshi Wakita, Tsuneaki Hirakawa, et al.
Blood|October 26, 2011
AAV8 vector expressing IL24 efficiently suppresses tumor growth mediated by specific mechanisms in MLL/AF4-positive ALL model miceHayato Tamai, Koichi Miyake, Hiroki Yamaguchi, et al.
International Journal of Hematology|April 30, 2025
Targeting EBV-infected T cells with alemtuzumab: a novel approach to systemic chronic active EBV diseaseKeimi Segami, Akihiro Yokoyama, Ayaka Ohashi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 26, 2006
[Low dose whole lung irradiation for intractable pleural effusion due to idiopathic myelofibrosis]Satoshi Wakita, Hiroki Yamaguchi, Masahiro Okabe, et al.
Cancer Research|June 25, 2017
Amlexanox Downregulates S100A6 to Sensitize <i>KMT2A/AFF1</i>-Positive Acute Lymphoblastic Leukemia to TNFα TreatmentHayato Tamai, Hiroki Yamaguchi, Koichi Miyake, et al.
Pageof 2